Share the post "Gujarat Terce Laboratories announced Financial Results Q1 2024-25"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 10.94 % in the past year, decrease in net sales/revenue by -2.61 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -3.95 %, Marginal decrease of -10.98% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for Gujarat Terce Laboratories Ltd. Profit dropped by -94.04 % Year to Year, Gujarat Terce Laboratories Ltd’s profitability dropped by -114.34 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -94.32 % Year to Year. EPS decreased by -113.7 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 10.717 Cr | Rs. 12.207 Cr | Rs. 11.889 Cr | -2.61 % | + 10.94 % |
| Expenses | Rs. 11.84 Cr | Rs. 11.2 Cr | Rs. 11.81 Cr | + 5.45 % | -0.25 % |
| Operating Profit | Rs. -1.12 Cr | Rs. 1.01 Cr | Rs. 0.08 Cr | -92.08 % | + 107.14 % |
| OPM % | -10.45 % | 8.27 % | 0.67 % | -7.6 % | + 11.12 % |
| Other Income | Rs. 0.076 Cr | Rs. 0.082 Cr | Rs. 0.073 Cr | -10.98 % | -3.95 % |
| Interest | Rs. 0.17 Cr | Rs. 0.15 Cr | Rs. 0.13 Cr | -13.33 % | -23.53 % |
| Depreciation | Rs. 0.09 Cr | Rs. 0.09 Cr | Rs. 0.09 Cr | + 0 % | + 0 % |
| Profit before tax | Rs. -1.3 Cr | Rs. 0.85 Cr | Rs. -0.07 Cr | -108.24 % | + 94.62 % |
| Tax % | -0 % | 35.66 % | -11.59 % | -47.25 % | -11.59 % |
| Net Profit | Rs. -1.31 Cr | Rs. 0.54 Cr | Rs. -0.08 Cr | -114.81 % | + 93.89 % |
| EPS in Rs | Rs. -1.76 | Rs. 0.73 | Rs. -0.1 | -113.7 % | + 94.32 % |
Today, we’re looking at Gujarat Terce Laboratories Ltd’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 10.94 %. However, it did see a marginal slip of -2.61 % from the previous quarter. Expenses ticked up slightly by 5.45 % quarter-on-quarter, aligning with the annual decline of -0.25 %. Operating profit, while up 107.14 % compared to last year, faced a quarter-on-quarter dip of -92.08 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 11.12 %, but a shrinkage of -7.6 % sequentially. Other income fell by -10.98 % compared to the last quarter, despite an annual decline of -3.95 %. Interest expenses dropped significantly by -13.33 % from the previous quarter, yet the year-over-year decrease remains at a moderate -23.53 %. Depreciation costs climbed by 0 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 0 %. Profit before tax grew annually by 94.62 % but saw a reduction from the preceding quarter by -108.24 %.
Tax expenses as a percentage of profits decreased slightly by -11.59 % compared to last year, with a more notable quarter-on-quarter decrease of -47.25 %. Net profit rose by 93.89 % year-on-year but witnessed a -114.81 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 94.32 % but a quarterly fall of -113.7 %. In summary, Gujarat Terce Laboratories Ltd’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 10.717 Cr | Rs. 12.207 Cr | Rs. 11.889 Cr | -2.61 % | + 10.94 % |
| Expenses | Rs. 11.84 Cr | Rs. 11.2 Cr | Rs. 11.81 Cr | + 5.45 % | -0.25 % |
| Operating Profit | Rs. -1.12 Cr | Rs. 1.01 Cr | Rs. 0.08 Cr | -92.08 % | + 107.14 % |
| Net Profit | Rs. -1.31 Cr | Rs. 0.54 Cr | Rs. -0.08 Cr | -114.81 % | + 93.89 % |
| EPS in Rs | Rs. -1.76 | Rs. 0.73 | Rs. -0.1 | -113.7 % | + 94.32 % |
In reviewing Gujarat Terce Laboratories Ltd’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 10.94 % year-on-year growth, although there was a slight dip of -2.61 % from the previous quarter. Expenses decreased by -0.25 % compared to the previous year, with a 5.45 % increase quarter-on-quarter. Operating Profit surged by 107.14 % annually, and saw a -92.08 % decrease from the last quarter.
Net Profit showed yearly increase of 93.89 %, and experienced a -114.81 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 94.32 % annually, however dipped by -113.7 % compared to the last quarter. In essence, while Gujarat Terce Laboratories Ltd exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
